Price movement over the last 24 hours
Act I : The AI Prophecy vs Enzyme — how do they compare? Act I : The AI Prophecy trades at Rp161.85 (market cap Rp152,08M, Rp883,66M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Act I : The AI Prophecy and Enzyme are close in size by market cap, and Act I : The AI Prophecy's circulating supply is 948,2M ACT versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Act I : The AI Prophecy for 37 Days and Enzyme for 28 Days on average.
| ACT | MLN | |
|---|---|---|
Market Cap | Rp152,08M | Rp134,13M |
Volume (24h) | Rp883,66M | Rp104,56M |
Circulating Supply | 948,2M ACT | 3,3M MLN |
Typical Hold Time | 37 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
ACT is currently trading at Rp149.128 with a market cap of Rp141.12M, showing bearish technical signals overall despite bullish oscillators. The token faces immediate resistance at Rp156 and support at Rp147, with RSI_6 at 14.39 indicating potential oversold conditions. Recent ecosystem activity shows limited protocol updates, with the token maintaining a 37-day average hold time.
Overall outlook remains cautious due to bearish technical structure, though oversold conditions suggest potential for short-term bounce. Key risks include low liquidity and limited recent development activity. Opportunities exist if the token can break above key resistance levels with increased volume.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Act I: The AI Prophecy Project (commonly known as Act I) is an open-source, decentralized platform that fosters unique interactions between AI systems. It aims to create an ecosystem where various AI, powered by a specialized token called ACT, can collaborate with each other and human users. Act I seeks to redefine traditional AI chatbots by emphasizing creativity over the standard “helpful, harmless, and honest” principles. By enabling collaboration between different types of AI, such as text and image generators, Act I strives to advance the development of more sophisticated AI technologies.
Read more on ACT →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →